U.K. mulls R&D tax credits for midsize biotechs

12/3/2004 | Reuters

The U.K.'s chancellor of the exchequer says he intends to review a tax credit given to medium-sized biotech and drug companies for research and development with an eye to increasing them as a way to encourage the industry. Gordon Brown also said he would end tax barriers that block spin-off companies created by universities. The drug industry applauded the promised move.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD